Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Pieters, Rob"'
Autor:
Pieters, Rob, Hunger, Stephen P., Boos, Joachim, Rizzari, Carmelo, Silverman, Lewis, Baruchel, Andre, Goekbuget, Nicola, Schrappe, Martin, Ching-Hon Pui
Publikováno v:
Cancer (0008543X); Jan2011, Vol. 117 Issue 2, p238-249, 12p
Autor:
Pearson AD; ACCELERATE, Europe. Electronic address: andy1pearson@btinternet.com., Rossig C; University Children´s Hospital Muenster, Pediatric Hematology and Oncology, Germany., Mackall C; Department of Pediatrics and Medicine, Stanford University, Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, CA, USA., Shah NN; Pediatric Oncology Branch, National Cancer Institute, USA., Baruchel A; Hôpital Universitaire Robert Debré (APHP) and Université de Paris, France., Reaman G; US Food and Drug Administration, USA., Ricafort R; Bristol Myers Squibb Company/Celgene, a BMS Company, USA., Heenen D; KickCancer, Belgium., Bassan A; Syncopation Life Sciences, USA., Berntgen M; Scientific Evidence Generation Department, Human Medicines Division, European Medicines Agency (EMA), Amsterdam, Netherlands., Bird N; Solving Kids' Cancer, UK., Bleickardt E; Novartis, USA., Bouchkouj N; US Food and Drug Administration, USA., Bross P; US Food and Drug Administration, USA., Brownstein C; Cellectis, USA., Cohen SB; CRISPR Therapeutics, Switzerland., de Rojas T; ACCELERATE, Europe., Ehrlich L; US Food and Drug Administration, USA., Fox E; St Jude Children's Research Hospital, USA., Gottschalk S; St Jude Children's Research Hospital, USA., Hanssens L; Miltenyi Biomedicine, Germany., Hawkins DS; Seattle Children's Hospital, USA., Horak ID; Tessa Therapeutics, Singapore., Taylor DH; Paediatric Oncology Reference Team (PORT), London, UK., Johnson C; US Food and Drug Administration, USA., Karres D; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Medicines Division, European Medicines Agency (EMA), Amsterdam, Netherlands., Ligas F; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Medicines Division, European Medicines Agency (EMA), Amsterdam, Netherlands., Ludwinski D; Solving Kids' Cancer, USA., Mamonkin M; Baylor College of Medicine, USA., Marshall L; The Royal Marsden Hospital and the Institute of Cancer Research, London, UK., Masouleh BK; Kite, a Gilead Company, USA., Matloub Y; Takeda Pharmaceuticals International, USA., Maude S; Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, USA., McDonough J; The Andrew McDonough B+ Foundation, USA., Minard-Colin V; Department of Pediatric and Adolescent Oncology, INSERM U1015, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Norga K; Antwerp University Hospital, Paediatric Committee of the European Medicines Agency, Federal Agency for Medicines and Health Products, Belgium., Nysom K; Rigshospitalet, Denmark., Pappo A; St Jude Children's Research Hospital, USA., Pearce L; GlaxoSmithKline, USA., Pieters R; Princess Maxima Center for Pediatric Oncology, Netherlands., Pule M; Autolus Limited, UK., Quintás-Cardama A; TCR(2) Therapeutics, USA., Richardson N; US Food and Drug Administration, USA., Schüßler-Lenz M; Chair of CAT (Committee for Advanced Therapies), European Medicines Agency (EMA), Amsterdam, Netherlands; Paul-Ehrlich-Institut, Germany., Scobie N; Zoe4Life, Switzerland., Sersch MA; Gracellbiotechnologies Inc, China., Smith MA; National Cancer Institute, USA., Sterba J; University Hospital Brno, Masaryk University, Brno, Czech Republic., Tasian SK; Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, USA., Weigel B; University of Minnesota, USA., Weiner SL; Children's Cancer Cause, USA., Zwaan CM; Princess Maxima Center for Pediatric Oncology, Netherlands; Haematological Malignancies Co-Chair Innovative Therapies for Children with Cancer Consortium (ITCC), Europe; Erasmus University Medical Center Rotterdam, Netherlands., Lesa G; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Medicines Division, European Medicines Agency (EMA), Amsterdam, Netherlands., Vassal G; ACCELERATE, Europe; Department of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Jan; Vol. 160, pp. 112-133. Date of Electronic Publication: 2021 Nov 25.
Autor:
Kearns PR; Cancer Research UK Clinical Trials Unit, National Institute for Health Research Birmingham Biomedical Research Centre, Institute of Cancer and Genomic Sciences, University of Birmingham, B15 2TT Birmingham, UK. Electronic address: p.r.kearns@bham.ac.uk., Vassal G; Department of Clinical Research, Gustave Roussy, Villejuif, France; Paris-Sud University, Orsay, France., Ladenstein R; Department of Pediatrics, St Anna Children's Hospital, Medical University, Vienna, Austria; Studies and Statistics of Integrated Research and Projects, Children's Cancer Research Institute, Vienna, Austria., Schrappe M; Department of Pediatrics and Adolescent Medicine I, Christian-Albrechts-University and University Medical Center Schleswig-Holstein, Campus, Kiel, Germany., Biondi A; Department of Pediatrics, University of Milano-Bicocca, Fondazione MBBM/Ospedale San Gerardo, Monza, Italy., Blanc P; Management Department, Unite2Cure, Europe; Imagine for Margo, Fourqueux, France., Eggert A; Department of Paediatrics, Department of Oncology and Hematology, Charité University Hospital of Berlin, Berlin, Germany., Kienesberger A; Management Department, Childhood Cancer International-Europe, Österreichische Kinder-Krebs-Hilfe, Vienna, Austria; Österreichische Kinder-Krebs-Hilfe, Vienna, Austria., Kozhaeva O; Policy Department, European Society for Paediatric Oncology - SIOP Europe, Brussels, Belgium., Pieters R; Medical Department, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Schmiegelow K; Department of Pediatrics and Adolescent Medicine, Rigshospitalet University Hospital, and Institute of Clinical Medicine, Faculty of Medicine, University of Copenhagen, Copenhagen, Denmark.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2019 Sep; Vol. 20 (9), pp. 1200-1202.
Autor:
Pritchard-Jones K; Institute of Child Health, University College London, London, UK. k.pritchard-jones@ucl.ac.uk, Pieters R, Reaman GH, Hjorth L, Downie P, Calaminus G, Naafs-Wilstra MC, Steliarova-Foucher E
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2013 Mar; Vol. 14 (3), pp. e95-e103. Date of Electronic Publication: 2013 Feb 20.